{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:42:56Z","timestamp":1770086576424,"version":"3.49.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Vincristine (VCR) is one of the main drugs of acute lymphoblastic leukemia (ALL) treatment. Azole antifungal medications are used for treatment or prophylaxis of invasive fungal infections in acute leukemia. Coadministration of these drugs increases the risk of VCR toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Observations:<\/jats:title><jats:p>We presented a girl with ALL using posaconazole prophylaxis. She developed VCR toxicity that included tubulopathy, high blood pressure, neuropathic pain, difficulty walking, diffuse muscular weakness, constipation, abdominal pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>There are limited data in children with ALL for posaconazole prophylaxis. We recommend that VCR side effects should be evaluated by careful monitoring of the patients who are on this combination therapy.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mph.0000000000001022","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T13:44:05Z","timestamp":1512567845000},"page":"e309-e310","source":"Crossref","is-referenced-by-count":18,"title":["Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"40","author":[{"given":"Esra","family":"Pekpak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"\u0130leri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"\u0130nce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ertem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00fcmr\u00fct","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/j.1875-9114.1998.tb03152.x","article-title":"Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports","volume":"18","author":"Chan","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/11319340-000000000-00000","article-title":"Pharmacokinetic\/pharmacodynamic profile of posaconazole","volume":"49","author":"Li","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1040-8428(98)00023-7","article-title":"Vincristine revisited","volume":"29","author":"Gidding","year":"1999","journal-title":"Crit Rev Oncol Hematol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases","volume":"55","author":"Moriyoma","year":"2012","journal-title":"Mycoses"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pbc.22161","article-title":"Vincristine: can its therapeutic index be enhanced?","volume":"53","author":"Moore","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPH.0b013e31819b9d01","article-title":"Posaconazole-increased vincristine neurotoxicity in a child. A case report","volume":"31","author":"Eiden","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20230918","first-page":"135","article-title":"Prolonged vincristine toxicity induced by concurrent posaconazole in a child with T-cell acute lymphoblastic leukemia","volume":"38","author":"Alavi","year":"2013","journal-title":"Iran J Med Sci"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/pbc.22399","article-title":"Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine","volume":"54","author":"Jain","year":"2010","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201807000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T13:47:31Z","timestamp":1719668851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201807000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001022","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}